With an ever-growing world population and increasing life-expectancy, the incidence of different types of cancer is expected ...
Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime, and the risk varies depending on age and race.
PET/CT offers excellent accuracy in the staging of high-risk prostate cancer (PCa), yet outcomes-based evidence of the clinical benefit remains limited. We aimed to determine whether the rates of ...
Thousands of men suffering from prostate cancer are set to gain access to a life-extending drug on the NHS following a significant expansion of eligibility criteria. Previously, the hormone therapy ...
Mark Stein, MD, explores managing mHSPC through PSMA PET imaging, tumor burden assessment, and AMPLITUDE trial data while considering clinical context. The widespread adoption of PSMA PET imaging has ...
Prostate cancer is the most common cancer among men.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results